Endophytic Fungi as Alternative and Reliable Sources for Potent Anticancer Agents by Omeje, Edwin O. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Endophytic Fungi as Alternative and Reliable Sources
for Potent Anticancer Agents
Edwin O. Omeje, Joy E. Ahomafor,
Theophilus U. Onyekaba, Philip O. Monioro,
Ibekwe Nneka, Sunday Onyeloni,
Charles Chime and Jonathan C. Eboka
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/67797
Abstract
In comparison with other natural sources like plants, highly diverse microorganisms are 
narrowly explored, especially with respect to their limitless potentials as repositories of 
exceptionally bioactive natural products. Of these organisms, fungi inhabiting tissues of 
plant in a noninvasive relationship (endophytic fungi) have proven undeniably useful 
and unmatchable as sources of potent bioactive molecules against several diseases such 
as cancer and related ailments. In general terms, endophytic fungi are highly prevalent 
organisms found in the tissue (intracellular or intercellular) of plants and at least for rea-
sonable portion of their lives. It has been proven that virtually every plant, irrespective 
of habitat and climate, plays host to wide varieties of endophytes. Endophytic fungi pro-
duce metabolites produced by different biosynthetic pathways to that of the host plant, 
and this robustness equips them to synthesize unlimited structural entities and scaffolds 
of diverse classes. Interestingly too, the cohabitation/culture of these fungi with certain 
bacteria offers even stronger hopes for anticancer drug discovery. The endless need for 
potent drugs has necessitated the search of bioactive molecules from several sources, and 
endophytic fungi appear to be a recipe. This chapter is an attempt to present the current 
trend of research with these very promising organisms.
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1. Introduction: the emergence of interest in endophytic fungi as  
sources of bioactive metabolites
Despite the fact that plant natural products (secondary metabolites) have been recognized as 
the most successful source of potential drug leads [1, 2], their recent implementation in drug 
discovery and development efforts have somewhat demonstrated a decline in interest [1]. 
Consequently, the need for new compounds to provide mitigation and relief in diverse human 
clinical conditions is ever-growing. In addition, the challenges of bacterial drug resistance, the 
emergence of highly virulent viruses and bacteria with organ transplant-associated complica-
tions demand very drastic drug discovery approaches in order to address them [3]. From the 
earliest times, when man directly tested plant materials for their potentials as medicines or 
foods to today when structured research approach has led to advancements in the discovery 
of bioactive natural product, it is evident that so much has been achieved in terms of the num-
ber of such agents that have great clinical importance. Notwithstanding, less than 10% of the 
world’s biodiversity has been evaluated for potential biological activity, and therefore, many 
more useful natural lead compounds await discovery with the challenge being how to access 
this natural chemical diversity [4]. The search for bioactive natural products with potentials 
of addressing these identified challenges is as old as man’s existence and has always relied 
heavily on the study of whole plant tissues (morphological parts) such as the roots (bark and 
inner tissues), leaves, stem (bark and inner tissues) and animal sources [5]. Unfortunately, 
the use of whole plant or animal tissues for the isolation of bioactive natural products has 
not been without its serious challenges. Fundamentally, the process leads to destruction of 
whole plant over time as the tissues are repeatedly collected without replenishment; most 
times, the existence of these plant species becomes threatened (endangered) and they are 
even lost after some years. Closely associated with this remarkable challenge are the problems 
of environmental degradation, land spoilage and the usually limited yield of the identified 
bioactive natural products. Secondly, the use of whole plant tissues in search of bioactive nat-
ural products has comparatively witnessed great wastage of research resources as a result of 
dereplication. Dereplication, which describes the process of fastly identifying or re-isolating 
already established biomolecules, is not only time and resources wasting but also discourages 
research zeal and excitement (reduction in interest). As at today, the probability of finding a 
novel bioactive molecule or chemical scaffold from whole tissues has further reduced because 
of dereplication. There are usually cross-family interactions among plant species in different 
biotopes complicated by most times poorly identified plant species, and as such, dereplica-
tion becomes a common challenge. Besides, the plant material has fixed biogenetic pathways 
which are tightly controlled by nature to produce predetermined secondary metabolites. As 
such and apart from the herculean plant tissue technology, man has little or no control over 
what a natural plant material produces as secondary metabolites. These identified problems 
led to loss of popularity in the natural product research efforts and, consequently, the devel-
opment of combinatorial chemistry. Despite the great chemistry and huge investments wit-
nessed in this era, not much breakthroughs have been recorded and, besides, combinatorial 
chemistry should act as a compliment to the natural product chemistry [6]. At this point, there 
arose a dire need for paradigm shift in the search for bioactive natural products. Accordingly, 
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over a decade ago and based on accumulated successful drug discovery story, it appeared 
that the search for novel secondary metabolites should be refocused and research efforts con-
sequently centered on the organisms that inhabit unique biotopes [1]. Of these organisms, 
endophytes were quickly recognized as veritable sources of novel bioactive natural products. 
Endophytes have been viewed as outstanding sources of novel products because there are so 
many of them occupying literally millions of unique biological niches (higher plant) growing 
in so many unusual environments. In all these, the endophytic fungi have been shown to be 
exceptionally useful in the drug discovery process, especially in the western world. An inten-
sive literature search revealed that endophytic populations of the plants in rain forests of the 
African continent have not been significantly explored. Regrettably, sketchy research data 
have largely been documented on few usually unharnessed and abridged studies with whole 
plant tissues. This apparent low interest in researches with microbes as sources of antimetab-
olites is much more worrisome in trans-Saharan Africa. The reasons are not farfetched, mainly 
owed to weak infrastructural framework and systems. In Nigeria, for example, which is the 
acclaimed most populous black nation in Africa (approximately 160 million people—2006 
National Population Census data), there are large rainforest zones in strategic locations of the 
country. Unfortunately, despite this robust biodiversity in Nigeria, bioprospecting for active 
molecules from these interesting microbes has remained largely unharnessed, and even the 
few research efforts have relied heavily on the direct plant tissues, with little work on the 
potentialities of fungal endophytes as veritable sources of novel bioactive compounds. This 
is a serious aberration and a major affront against any meaningful drug discovery effort of 
not only in Nigeria but also in several other African Countries. Consequently, there is need 
to awaken and boost research interest in the use of these specialized microbes (endophytes) 
for the discovery of potent bioactive molecules against the ever-increasing disease burden 
globally. In addition, given the rapidly increasing population of Nigeria and accompany-
ing demand for drugs, it is critically important to identify and develop renewable sources 
of pharmaceuticals and their precursors. It is in line with this thought that we proposed this 
book chapter on endophytes as alternative and reliable sources of potent anticancer agents. 
It is our modest expectation that, through concerted research efforts in this promising area of 
drug discovery process, several strongly potent and safe molecules will be identified, isolated, 
assayed, characterized and hopefully progress into the several stages of clinical trial program 
as potential part of the armamentarium against cancer and associated conditions.
2. Endophytic fungi and search for active metabolites
The use of microbial biotopes as reliable sources of bioactive natural products has received 
significant attention so far [7, 8]. Current available data reveal that more than 40% of novel 
potent bioactive molecules obtained in a period of nearly two and half decades and half were 
microorganism-derived. Furthermore, over 60% of the anticancer and 70% of the antimicro-
bial drugs currently in clinical use are natural products or natural product derivatives. This is 
not surprising in the light of their evolution over millions of years in diverse ecological niches 
and natural habitats. The avalanche of microbial diversity with exciting metabolic complexes 
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in plant tissues has been established in the last two decades and is continuing [8]. It is expedi-
ent to emphasize that the discovery of an endophytic fungus, from Taxus brevifolia, which pro-
duces highly selling anticancer agent called taxol, precipitated a surge in interest to researches 
with endophytes [9]. Accordingly, about a decade ago, it appeared that the search for novel 
secondary metabolites should be refocused and research efforts consequently centered on the 
organisms that inhabit unique biotopes [1]. Of these organisms, endophytes were recognized 
as veritable sources of novel bioactive natural products. Endophytes have been viewed as out-
standing sources of novel products because there are so many of them occupying literally mil-
lions of unique biological niches (higher plant) growing in so many unusual environment. One 
very interesting feature of the endophytic fungi is that they are renewable, readily available 
and environmentally friendly sources of biologically active natural products. An intensive lit-
erature search revealed that endophytic populations of the plant in rain forests of the African 
continent have not been studied apart from few unharnessed studies with whole plant tissues. 
Despite this ugly and unacceptable picture, it is heartening to note that this trend is gradually 
changing as current research scholars of African origin, especially those from Nigeria and 
Cameroun with thrust in natural product chemistry focus more on endophytic fungi nowa-
days as compared to the use of whole plant tissues. In summary, the inadequacy of systematic 
exploitation of ecosystems for the discovery of novel microbial compounds had resulted in 
random sampling and has missed the true potential of many regions [10]. Numerous bioactive 
molecules have been isolated from endophytic fungi since this ground-breaking discovery 
[11–13]. It is known that these endophytic fungi are embedded within plant for a substantial 
part of their life cycle and, as well earlier stated, they are devoid of any established potential 
to cause diseases in the host [14, 15]. This attribute makes this class of microbes a unique 
resource base for the discovery and development of potent anticancer molecules without hav-
ing to destroy whole plant tissues. Additionally, they have been found to be more active when 
compared to other types of fungi somewhat existing outside the host in terms of metabolic 
virility [6, 16]. It was previously thought that metabolic products are transferred between host 
plant and the endophyte, the theory of horizontal transfer from the host plant to its microbial 
symbiont [9, 11, 17, 18]. This belief has been disproved following the successful sequencing 
of the taxadiene synthase gene from the taxol-producing endophyte which established that the 
metabolic pathways of both the hosts and the endophytes are independent of each other. The 
implication of this is that there are ample opportunities available for the manipulation of the 
endophyte biosynthetic pathways [19] to yield wide varieties of molecules and scaffolds for 
drug discovery process. ‘Endophytism’ is, thus, a unique cost–benefit plant microbe associa-
tion defined by ‘location’ (not ‘function’) that is transiently symptomless, unobstructive, and 
established entirely inside the living host plant tissues [20, 21]. Evidence of plant-associated 
microorganisms found in the fossilized tissues has revealed that endophyte-plant associa-
tions may have evolved from the time higher plants first appeared on the earth surface [22]. 
The existence of fungi inside the organs of asymptomatic plants has been known since the 
end of the nineteenth century [23], and the term, ‘endophyte’ was first proposed in 1866 [24]. 
Since their discovery and description, they have been isolated from various organs of differ-
ent plant species, from aboveground tissues of liverworts, hornworts, mosses, lycophytes, 
equisetopsides, ferns and spermatophytes from the tropics to the arctic, and from the wild to 
agricultural ecosystems [25]. Interestingly, all plant species studied till date have been found 
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to harbor at least one endophyte. The most frequently encountered endophytes are fungi or 
bacteria (including actinomycetes), but future projections suggest that there could be revela-
tion of nonendophytic microorganisms [3]. Endophytic fungi are a very diverse polyphyletic 
group of microorganisms; they can thrive asymptomatically in the tissues of plants aboveg-
round as well as belowground, including stems, leaves and/or roots [26]. Many endophytes 
have the potential to synthesize various bioactive metabolites that may directly or indirectly 
be used as therapeutic agents against numerous diseases [3, 19, 21, 27–29]. Occasionally and 
usually hitting major buck, endophytes that produce host plant secondary metabolites with 
therapeutic value or potentials have been discovered; some examples include paciltaxel (also 
known as taxol) [9] and podophyllotoxin [17, 30]. The production of bioactive compounds 
by endophytes, especially those exclusive to their host plant, is not only important from an 
ecological perspective but also from a biochemical and molecular standpoint. In contrast to 
the direct bioprospecting with known medicinal plants (the common problem being that of 
dereplication), exciting possibilities exist for exploiting endophytic fungi for the production 
of a plethora of known and novel biologically active secondary metabolites. The potential 
of microorganisms is further limited by the presence of orphan biosynthetic pathways that 
remain unexpressed under general laboratory conditions [31]. However, the vast choice of 
techniques pertaining to the growth and manipulation of microorganisms such as media engi-
neering, coculture, chemical induction, epigenetic modulation and metabolite remodeling, 
coupled with the fermentation technology for scale-up, make them suitable for production of 
useful natural products, both known and novel [16]. Of the myriads of ecosystems on earth, 
those having the greatest biodiversity seem to be ones also having endophytes with the great-
est number and the most biodiverse microorganisms. Tropical and temperate rain forests are 
the most biologically diverse terrestrial ecosystems on earth. As such, one would expect that 
areas of high plant endemicity also possess specific endophytes that may have evolved with 
the endemic plant species. Ultimately, biological biodiversity implies chemical biodiversity 
because of constant chemical innovation that exists in ecosystems where the evolutionary 
race to survive is most active. Comparatively, tropical rainforests are a remarkable example 
of this type of environment because competition is great; resources are limited, and selection 
pressure is at its peak. This gives rise to a high probability that rainforests are excellent source 
of novel molecular structures and biologically active compounds [32]. Early researches in 
endophyte bioprospecting showed that a significantly higher number of tropical endophytes 
produced a larger number of active secondary metabolites than did fungi from temperate 
endophytes or other tropical substrata [33].
3. Isolation process and characterization of bioactive metabolites from 
endophytic fungi
The choice of plants for the explorative study of endophytes in search of potent bioactive mol-
ecules is a very crucial issue that requires the right information. Since the biochemical pathways 
of both endophytes and their host are strongly correlated, it is expedient that medicinally use-
ful plants in different cultures are selected for bioprospecting of endophytes. The isolation of 
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 endophytic fungi is carried out using the most probable morphological part of the properly 
identified and document host plant, most times the leaves. The wholesome leaves of the selected 
plant are collected in sterile plastic bags from designated area with the aid of the geographic 
position system (GPS) and stored at refrigeration temperature (4°C) in preparation for the isola-
tion of endophytic fungi. There are times during which samples might have to be transported 
over long distances, and it is required that contingent transport and sterile cold chain arrange-
ments should be made to ensure the integrity of the plant part on arrival. In all the processes, it 
is required that strict sterility is maintained so as to ensure that no external organisms are intro-
duced as contaminants to the culture. The following procedures are then followed:
(i) The leaves or any other morphological part of interest is washed under flowing tap water 
for a minimum time of 10 min and dried under sterile dry air.
(ii) With the aid of a sterilized scalpel (use of Bunsen flame) or other techniques, pieces of 
the leaves are cut out and sterilized further using these agents; 95% ethanol (1–2 min), 
3.5% (v/v) sodium hypochlorite (3–4 min), 70% (v/v) ethanol (30–40 s) in that order.
(iii) The sterilized samples will be washed trice in sterile distilled water and allowed to dry 
on filter papers under aseptic conditions. Subsequently, the samples are placed on the 
appropriate culture media of interest supplemented with an antibiotic concentration to 
prevent the growth of bacteria and depending on the substrate that will act as the pri-
mary carbon source in the medium. Some of the natural carbon sources include maltose, 
rice, beans, etc. The plating is usually done in replicates and inside air laminar flow hood 
of appropriate level of biosafety.
(iv) The plates will then be incubated at room temperature (30–37°C). The fungal mycelium 
growing out from leaf discs were subsequently transferred to fresh MEA plates by hy-
phal tip transfers and incubated further at room temperature for 1–2 weeks. The purity 
of isolated endophytic fungi was checked and their antimicrobial and anticancer activity 
was determined. The endophytic fungal isolates were maintained in MEA for future 
studies. This is referred to as the primary culture. When the pure fungal species is iden-
tified and fully characterized (after affirmation of interesting activities in this instance, 
anticancer property using different robust in vitro techniques), large-scale production 
of the fungi will then involve the use of secondary culture technique in larger vessels 
for the harvest of larger quantity in preparation for isolation of the fungal metabolites. 
Sometimes, selected bacteria are cocultured with the fungi as a way of stimulating and 
manipulating and exploiting the metabolic pathways of these organisms. Modifications 
of these procedures vary from laboratory to laboratory.
4. Identification of endophytic fungal isolates
Essentially, isolated endophytic fungi are identified based on both their macroscopic and 
microscopic structures [34]. Further identification sequel to establishment of satisfactory bio-
logical activities involves the use of biotechnological procedures. There are several taxonomical 
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classification guides available such as found in these references [35–38]. The nonspores are 
termed and classified as mycelia isolates. The fungal isolates with very interesting biological 
activity spectrum are further identified based on the analysis of nucleotide sequences of the 
internal transcribed spacer (ITS) regions of rDNA following the method described by earlier 
authors [39]. The confirmation of similarity of gene properties of the synthesized nucleotide 
rDNA sequence of ITS is usually compared with sequences from available GenBank using 
BLAST program of the National Institutes of Health, United States of America.
5. Large-scale endophytic fungal cultivation and extraction
The large-scale cultivation of the endophytic fungi is also carried out on the selected media as 
described above and then transferred (inoculated) into a 500-ml or larger Erlenmeyer flasks 
containing appropriate nutrients depending on target. The setup will be incubated at room 
temperature for one month standard conditions. The broth is then filtered and extracted with 
an appropriate solvent such as ethyl acetate. The extract was dried over anhydrous sodium 
sulfate and then evaporated under vacuum in a rotary evaporator, to yield ethyl acetate 
extracts. The dried extract will be partitioned into several solvent fractions and recovered 
for further testing of biological activities. Subsequently, the fractions are subjected to several 
processes of chromatography and purifications steps to isolate pure metabolites which are 
tested and fully characterized using physicochemical and spectroscopic methods. In order 
to maximize the unlimited potentials of the endophytic fungi as reliable repository for anti-
cancer bioactive metabolites and other drug discovery, modern research should target the 
selection and isolation of samples from diverse ecosystems, manipulating microbial physiol-
ogy to activate microbial natural-product biosynthetic machinery, and genetically modifying 
strains for production of unnatural microbial natural products. By manipulating all three of 
these approaches, the diversity of an extract collection can be maximized, and in doing so, the 
chance of finding a ‘hit’ can be increased.
6. An overview of anticancer agents from endophytic fungi
Although some battles have been won since the declaration of the ‘war on cancer’ in 1971 
in the United Sates, the war is ongoing [40]. Furthermore, the much expected breakthrough 
in anticancer chemotherapy has been seriously challenged. Malignant tumors are one of 
the most serious diseases that damage human health in the modern world and the second 
 largest deadly disease just after heart diseases [41], and as such, the search for newer anti-
cancer agents remains endless. This search has, in recent times, shifted to the endophytic 
fungi. Interesting secondary metabolites are derived from endophytes which make them 
unmatchable synthesizers of very useful complex chemical scaffolds inside their hosts 
[42, 43]. In comparison, most of these metabolites have been engaged in the fight against 
diverse diseases of man and animal [44]. Since the advent of taxol from an endophytic fun-
gus, efforts have relied on the manipulation and optimization of the culture conditions and 
this approach has produced several chemical constituents and novel analogues with quite 
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unique  biochemistry [3]. For the purpose of this chapter, we limited our discussion to few 
selected important categories of bioactive metabolites produced by fungal endophytes of 
medicinal plants (Figure 1). Several authors in the past have reported excellent reviews on 
endophytes as potential sources of bioactive metabolites. One of such interesting reviews 
was published by Sanjana et al. [45] in 2012, covering their unmatched potentials as sources 
for anticancer, antioxidant, immunomodulatory, antiparasitic, antitubercular and insecticidal 
agents. In the current review, we attempt to present an updated chapter on endophytes as 
reliable sources of anticancer metabolites. Following the discovery of the multimillion dollar 
anticancer agent, taxol from the endophytic fungus Taxomyces andreanae [9], several others 
have been studied as potential repositories of anticancer agents. Taxol (paclitaxel) belongs 
to the diterpenoid class of natural products and is an exceptionally potent anticancer agent. 
Before, being isolated from the endophytic fungus Taxomyces andreanae, it was isolated for 
the first time, from the bark of Taxus brevifolia, commonly called yew plant from the South 
American pacific. The drug was subsequently approved by the Food and Drug Administration 
(FDA), USA, for the treatment of selected cancers [46]. The diverse sources of taxol from 
endophytic fungi are shown in Table 1. Lee et al. [47] reported the isolation of a dimeric 
quinone Torreyanic acid from the endophytic fungus, Pestalotiopsis microsporum growing 
in the plant Torreya taxifolia. This compound was shown to possess potent cytotoxic activ-
ity through apoptotic mechanisms [47]. Camptothecin, a potent antineoplastic agent from 
endophytic Entrophospora infrequens isolated from the host plant, Nothapodytes foetida, was also 
reported by Puri et al. [48], as having pronounced activity against lung cancer and ovarian 
cancer cell lines. Several authors attempted the derivatization of analogues of Campothecin, 
and a successful effort led to the discovery of two clinically useful anticancer drugs: topote-
can and irinotecan. These potent anticancer compounds were extracted from the endophytic 
Fusariumsolani inhabiting Camptotheca acuminata [18]. Podophyllotoxin, a nonalkaloid lignin 
and its analogues are clinically relevant mainly due to their antiviral and anticancer activi-
ties; further, they are the precursors of many other useful anticancer drugs including eto-
poside, Teniposide and etopophos phosphate [49]. Podophyllotoxin and other related aryl 
tetralin lignans have also been reported to be produced by another novel endophytic fungus, 
Trametes hirsute with anticancer potential [17]. The different strains of endophytic fungi pro-
ducing Podophyllotoxin are represented in Table 2. Various novel microbial sources of podo-
phyllotoxin include Aspergillus fumigatus isolated from Juniperus communis [50], Phialocephala 
fortinii isolated from Podophyllum  peltatum [30] and Fusarium oxysporum isolated from Juniperus 
recurva [49]. Ergoflavin, a novel anticancer agent, was isolated from the leaf endophytes of 
an Indian medicinal plant Mimusops elengi, belonging to family Sapotaceae. Ergoflavin is a 
dimeric xanthene linked at position-2, belonging to the ergochrome class of compounds [51]. 
Another compound from ergochrome class, i.e., secalonic acid D, a mycotoxin, isolated from 
the mangrove endophytic fungus also exhibits a good cytotoxic activity on HL60 and K562 
cells by inducing leukemia cell apoptosis [52]. Wagenaar et al. [53] studied Rhinocladiella 
sp. inhabiting Tripterygium wilfordii and reported three novel cytochalasins: cytochalasin H, 
cytochalasin J and epoxycytochalasin H along with a known compound cytochalasin E. These 
compounds have been identified as 22-oxa-12-cytochalasins and have antitumor activity. 
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Figure 1. Selected structures of anticancer metabolites from endophytic fungi.
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A novel cytotoxic cytochalasan-based alkaloid chaetoglobosin U along with four known ana-
logues, chaetoglobosin C, chaetoglobosin F, chaetoglobosin E and ponochalasin A, have been 
Endophytic fungus Fungal strain Host plant Paclitaxel yield (μg/L)
Alternaria sp. Ja-69 Taxus cuspidata 0.16
Alternaria sp. – Ginkgo biloba 0.12–0.26
Alternaria alternata TPF6 Taxus chinensis var. mairei 84.5
Aspergillus fumigatus EPTP-1 Podocarpus sp. 557.8
Aspergillus niger var. taxi HD86-9 Taxus cuspidata 273.6
Botryodiplodia theobromae BT115 Taxus baccata 280.5
Botrytis sp. XT2 Taxus chinensis var. mairei 161.24
Botrytis sp. HD181-23 Taxus cuspidata 206.34
Cladosporium cladosporioides MD2 Taxus media 800
Ectostroma sp. XT5 Taxus chinensis var. mairei 276.75
Fusarium arthrosporioides F-40 Taxus cuspidate  131
Fusarium lateritium Tbp-9 Taxus baccata 0.13
Fusarium mairei Y1117 Taxus chinensis var. mairei 2.7
Fusarium mairei UH23 Taxus chinensis var. mairei 286.4
Fusarium solani – Taxus celebica 1.6
Fusarium solani Tax-3 Taxus chinensis 163.35
Metarhizium anisopliae  H-27 Taxus chinensis 846.1
Monochaetia sp.  Tbp-2 Taxus baccata 0.10
Mucor rouxianus DA10 Taxus chinensis –
Ozonium sp. BT2 Taxus chinensis var. mairei 4–18
Papulaspora sp. XT17 Taxus chinensis var. mairei 10.25
Periconia sp. No. 2026 Torreya grandifolia 0.03–0.83
Pestalotia bicilia Tbx-2 Taxus baccata 1.08
Pestalotiopsis guepinii W-1f-2 Wollemia nobilis 0.49
Pestalotiopsis microspora Ja-73 Taxus cuspidata 0.27
Pestalotiopsis microspora Ne-32 Taxus wallachiana 0.5
Pestalotiopsis microspora  No. 1040 Taxus wallachiana 0.06–0.07
Pestalotiopsis microspora  Cp-4 Taxodium distichum 0.05–1.49
Pestalotiopsis microspora  Ne 32 Taxus wallichiana  0.34–1.83
Adapted from Zhao et al. (2010), Endophytic fungi for producing bioactive compounds originally from their host plants [62].
Table 1. Paclitaxel-producing endophytic fungi and their host plants.
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produced by the fungal endophyte Chaetomium globosum IFB-E019 isolated from Imperata 
cylindrica. Cheatoglobosin U exhibits cytotoxic activity against nasopharyngeal epidermoid 
tumor KB cell [54]. Chen et al. [55] reported Gliocladicillins A and B as effective antitumor 
agents in vitro and in vivo. They induced tumor cell apoptosis and also showed a signifi-
cant inhibition on proliferation of melanoma B16 cells implanted into immunodeficient mice. 
Vincristine, an alkaloid with cytotoxic activity, was isolated from the endophytic mycelia 
sterilia inhabiting Catharanthus roseus [56]. This drug is mainly used as a chemotherapy regi-
men in acute lymphoblastic leukemia and nephroblastoma. Likewise, there are large numbers 
of anticancer agents produced by fungal endophytes inhabiting different medicinal plants. 
Several of such molecules are presently at different levels of clinical trials, and there are puta-
tive hopes that some of them will be approved for use in no distant time. Furthermore, the list 
of metabolites obtained diverse endophytic fungi with proven potent activity against several 
cancers is endless, thus indicating that these organisms hold the future in the attempt to con-
quer cancer therapeutically.
7. Conclusion
No doubt, endophytes remain an unmatchable biodiversity and repository for novel natural 
compounds with useful biological activities and form simple to complex scaffolds for the 
generation of more potent of compound. Because of the diversity of potential of advantages 
including the application of modern biotechnological techniques, metabolic technology and 
microbial fermentation process, we can better understand and manipulate this important 
Endophytic fungus Fungal strain Host plant Podophyllotoxin content or yield
Alternaria sp. – Sinopodophyllum hexandrum 
(=Podophyllum hexandrum)
–
Alternaria neesex Ty Sinopodophyllum hexandrum 2.4 μg/L
Fusarium oxysporum JRE1 Sabina recurva (=Juniperus recurva) 28 μg/g
Monilia sp. – Dysosma veitchii –
Penicillium sp. – Sinopodophyllum hexandrum –
Penicillium sp. – Diphylleia sinensis –
Penicillium sp. – Dysosma veitchii –
Penicillium implicatum SJ21 Diphylleia sinensis –
Penicillium implication 2BNO1 Dysosma veitchii –
Phialocephala fortinii PPE5, PPE7 Sinopodophyllum peltatum 0.5–189 μg/L
Trametes hirsuta – Sinopodophyllum hexandrum 30 μg/g
Adapted from Zhao et al. (2010), Endophytic fungi for producing bioactive compounds originally from their host plants.
Table 2. Podophyllotoxin-producing endophytic fungi and their host plants.
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microorganism resource and make it more beneficial for the mankind [33, 57–60]. We can 
conclude that the endophytic fungi are a novel and important microbial resource for produc-
ing bioactive compounds and have attracted attention of many researchers on their theoretical 
study as well as their potential applications [61]. The future of discovering anticancer agents 
from endophytic fungi is undoubtedly bright.
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